H.R. 3271 · 115th Congress
Protecting Access to Diabetes Supplies Act of 2017
Key: what the circles and colors mean
Each circle is a bill. The ring fills as it moves through Congress:
Under the number: the Yea · Nay count of its final (or latest) recorded vote. On a member's page, the small badge is how that member voted: Y Yea / Aye, N Nay / No, P Present, – Not voting.
Gold and violet are only for Yea and Nay; they never mean a party. A member's party is the letter on their photo.
Never voted on. It didn't reach a floor vote before the 115th Congress ended, so it expired. A bill has to be introduced again to be considered in a new Congress.
D
DeGetteSponsor12 cosponsors · 12 R
R
Brooks
TR
R
Reed
BG
R
Guthrie
GB
R
Bilirakis
RD
R
Davis
LB
R
Bucshon
BJ
R
Johnson
ST
R
Tipton
RC
R
Costello
JW
R
Walorski
BL
R
Long
PR
R
Roskam2 signed on when it was introduced; the rest joined later. Cosponsors who withdrew aren't shown.
The CMS may terminate a contract if it determines that an entity, for reasons other than product discontinuation or market-wide shortage, fails to maintain ready access to such products included its bid.
What it does: CRS summary · Reported to House amended, Part I · Dec 6, 2017
Protecting Access to Diabetes Supplies Act of 2017
(Sec. 2) This bill amends title XVIII (Medicare) of the Social Security Act to modify provisions relating to Medicare's competitive acquisition program (through which rates are set through a competitive bidding program rather than by an established fee schedule) with respect to diabetic testing strips. Specifically, the bill requires the Centers for Medicare & Medicaid Services (CMS) to:
- use specified data to determine whether a bid satisfies certain requirements related to volume of coverage with respect to such products,
- reject a bid if the bidder does not demonstrate its ability to furnish such products in a manner consistent with its bid, and
- establish a process to monitor the extent to which an entity continues to cover the product types included in its bid.
The CMS may terminate a contract if it determines that an entity, for reasons other than product discontinuation or market-wide shortage, fails to maintain ready access to such products included its bid.
In addition, the bill specifies that an entity furnishing such products to beneficiaries under the program: (1) must furnish to each beneficiary a brand of strips that is compatible with the beneficiary's home blood glucose monitor, (2) may not attempt to influence or incentivize a beneficiary to switch the brand of either type of product, and (3) must contact and receive a request from a beneficiary no more than 14 days prior to dispensing a refill to the beneficiary.
Written by the nonpartisan Congressional Research Service. All summary versions on Congress.gov
About this bill and sources
Official title: Protecting Access to Diabetes Supplies Act of 2017
Latest action (Dec 6, 2017): Placed on the Union Calendar, Calendar No. 329.
Policy area: Health · Origin: House · Introduced: Jul 17, 2017
Official page on Congress.gov · Bill text (GovInfo) · Status record (XML)
No recorded floor vote found.